BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gutiérrez-Bautista JF, Rodriguez-Nicolas A, Rosales-Castillo A, Jiménez P, Garrido F, Anderson P, Ruiz-Cabello F, López-Ruz MÁ. Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset.Front Immunol. 2020;11:596553. [PMID: 33324414 DOI: 10.3389/fimmu.2020.596553] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Alcolea PJ, Larraga J, Rodríguez-martín D, Alonso A, Loayza FJ, Rojas JM, Ruiz-garcía S, Louloudes-lázaro A, Carlón AB, Sánchez-cordón PJ, Nogales-altozano P, Redondo N, Manzano M, Lozano D, Palomero J, Montoya M, Vallet-regí M, Martín V, Sevilla N, Larraga V. Non-replicative antibiotic resistance-free DNA vaccine encoding S and N proteins induces full protection in mice against SARS-CoV-2. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1023255] [Reference Citation Analysis]
2 Tan J, Li Y. Immune checkpoint alterations and their blockade in COVID-19 patients. Blood Sci 2022;4:192-8. [PMID: 36311817 DOI: 10.1097/BS9.0000000000000132] [Reference Citation Analysis]
3 Kudryavtsev IV, Arsentieva NA, Korobova ZR, Isakov DV, Rubinstein AA, Batsunov OK, Khamitova IV, Kuznetsova RN, Savin TV, Akisheva TV, Stanevich OV, Lebedeva AA, Vorobyov EA, Vorobyova SV, Kulikov AN, Sharapova MA, Pevtsov DE, Totolian AA. Heterogenous CD8+ T Cell Maturation and ‘Polarization’ in Acute and Convalescent COVID-19 Patients. Viruses 2022;14:1906. [DOI: 10.3390/v14091906] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Kalinina O, Golovkin A, Zaikova E, Aquino A, Bezrukikh V, Melnik O, Vasilieva E, Karonova T, Kudryavtsev I, Shlyakhto E. Cytokine Storm Signature in Patients with Moderate and Severe COVID-19. IJMS 2022;23:8879. [DOI: 10.3390/ijms23168879] [Reference Citation Analysis]
5 Milenkovic J, Djindjic B, Djordjevic B, Stojiljkovic V, Stojanovic D, Petrovic S, Matejic I. Platelet-derived immuno-inflammatory indices show best performance in early prediction of COVID-19 progression. J Clin Lab Anal 2022;:e24652. [PMID: 35949002 DOI: 10.1002/jcla.24652] [Reference Citation Analysis]
6 Palatella M, Guillaume SM, Linterman MA, Huehn J. The dark side of Tregs during aging. Front Immunol 2022;13:940705. [DOI: 10.3389/fimmu.2022.940705] [Reference Citation Analysis]
7 Kudryavtsev IV, Golovkin AS, Totolian AA. T helper cell subsets and related target cells in acute COVID-19. Russian Journal of Infection and Immunity 2022;12:409-26. [DOI: 10.15789/2220-7619-thc-1882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Stumpf J, Schwöbel J, Karger C, Schirutschke H, Mauer R, Klimova A, Tonn T, Hugo C. Anti-SARS-CoV-2 Revaccination Success in Kidney Transplant Recipients With No Initial Humoral Response Is Linked to Primary Vaccine Type. Front Med 2022;9:910987. [DOI: 10.3389/fmed.2022.910987] [Reference Citation Analysis]
9 Gutiérrez-bautista JF, Martinez-chamorro A, Rodriguez-nicolas A, Rosales-castillo A, Jiménez P, Anderson P, López-ruz MÁ, López-nevot MÁ, Ruiz-cabello F. Major Histocompatibility Complex Class I Chain-Related α (MICA) STR Polymorphisms in COVID-19 Patients. IJMS 2022;23:6979. [DOI: 10.3390/ijms23136979] [Reference Citation Analysis]
10 Kudryavtsev I, Rubinstein A, Golovkin A, Kalinina O, Vasilyev K, Rudenko L, Isakova-sivak I. Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview. Viruses 2022;14:1082. [DOI: 10.3390/v14051082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Hsu RJ, Yu WC, Peng GR, Ye CH, Hu S, Chong PCT, Yap KY, Lee JYC, Lin WC, Yu SH. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections. Front Immunol 2022;13:832394. [PMID: 35464491 DOI: 10.3389/fimmu.2022.832394] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
12 Garcia-Gasalla M, Berman-Riu M, Pons J, Rodríguez A, Iglesias A, Martínez-Pomar N, Llompart-Alabern I, Riera M, Ferré Beltrán A, Figueras-Castilla A, Murillas J, Ferrer JM. Hyperinflammatory State and Low T1 Adaptive Immune Response in Severe and Critical Acute COVID-19 Patients. Front Med (Lausanne) 2022;9:828678. [PMID: 35425776 DOI: 10.3389/fmed.2022.828678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ahmadi E, Bagherpour Z, Zarei E, Omidkhoda A. Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function. Pathology - Research and Practice 2022;231:153782. [DOI: 10.1016/j.prp.2022.153782] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Gil-Manso S, Miguens Blanco I, López-Esteban R, Carbonell D, López-Fernández LA, West L, Correa-Rocha R, Pion M. Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals. Front Immunol 2021;12:793142. [PMID: 35069575 DOI: 10.3389/fimmu.2021.793142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gil-etayo FJ, Garcinuño S, Utrero-rico A, Cabrera-marante O, Arroyo-sanchez D, Mancebo E, Pleguezuelo DE, Rodríguez-frías E, Allende LM, Morales-pérez P, Castro-panete MJ, Lalueza A, Lumbreras C, Paz-artal E, Serrano A. An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution. Biomedicines 2022;10:296. [DOI: 10.3390/biomedicines10020296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
16 Fouladseresht H, Ghamar Talepoor A, Eskandari N, Norouzian M, Ghezelbash B, Beyranvand MR, Nejadghaderi SA, Carson-chahhoud K, Kolahi A, Safiri S. Potential Immune Indicators for Predicting the Prognosis of COVID-19 and Trauma: Similarities and Disparities. Front Immunol 2022;12:785946. [DOI: 10.3389/fimmu.2021.785946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 García-silva I, Colunga-saucedo M, Almendarez-rodríguez C, Miranda-lópez C, Rosales-mendoza S, Comas-garcia M. Virus-like particle-based vaccines against SARS-CoV-2. Biomedical Innovations to Combat COVID-19 2022. [DOI: 10.1016/b978-0-323-90248-9.00005-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gil-manso S, Miguens Blanco I, Motyka B, Halpin A, López-esteban R, Pérez-fernández VA, Carbonell D, López-fernández LA, West L, Correa-rocha R, Pion M. ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2. Virulence 2022;13:30-45. [DOI: 10.1080/21505594.2021.2019959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Kudryavtsev IV, Arsentieva NA, Batsunov OK, Korobova ZR, Khamitova IV, Isakov DV, Kuznetsova RN, Rubinstein AA, Stanevich OV, Lebedeva AA, Vorobyov EA, Vorobyova SV, Kulikov AN, Sharapova MA, Pevtcov DE, Totolian AA. Alterations in B Cell and Follicular T-Helper Cell Subsets in Patients with Acute COVID-19 and COVID-19 Convalescents. CIMB 2022;44:194-205. [DOI: 10.3390/cimb44010014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
20 Barnova M, Bobcakova A, Urdova V, Kosturiak R, Kapustova L, Dobrota D, Jesenak M. Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19. Physiol Res 2021;70:S227-47. [PMID: 34913354 DOI: 10.33549/physiolres.934757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
21 Golovkin A, Kalinina O, Bezrukikh V, Aquino A, Zaikova E, Karonova T, Melnik O, Vasilieva E, Kudryavtsev I. Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19. Viruses 2021;13:1966. [PMID: 34696395 DOI: 10.3390/v13101966] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 22.0] [Reference Citation Analysis]
22 Torres-Ruiz J, Pérez-Fragoso A, Maravillas-Montero JL, Llorente L, Mejía-Domínguez NR, Páez-Franco JC, Romero-Ramírez S, Sosa-Hernández VA, Cervantes-Díaz R, Absalón-Aguilar A, Nuñez-Aguirre M, Juárez-Vega G, Meza-Sánchez D, Kleinberg-Bid A, Hernández-Gilsoul T, Ponce-de-León A, Gómez-Martín D. Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes. Front Immunol 2021;12:689966. [PMID: 34566957 DOI: 10.3389/fimmu.2021.689966] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
23 Vargas-Mendoza N, García-Machorro J, Angeles-Valencia M, Martínez-Archundia M, Madrigal-Santillán EO, Morales-González Á, Anguiano-Robledo L, Morales-González JA. Liver disorders in COVID-19, nutritional approaches and the use of phytochemicals. World J Gastroenterol 2021;27:5630-65. [PMID: 34629792 DOI: 10.3748/wjg.v27.i34.5630] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Li M, Zhang Y, Lu J, Li L, Gao H, Ma C, Dai E, Wei L. Asymptomatic COVID-19 Individuals Tend to Establish Relatively Balanced Innate and Adaptive Immune Responses. Pathogens 2021;10:1105. [PMID: 34578138 DOI: 10.3390/pathogens10091105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Gong J, Zhan H, Liang Y, He Q, Cui D. Role of Th22 Cells in Human Viral Diseases. Front Med (Lausanne) 2021;8:708140. [PMID: 34434945 DOI: 10.3389/fmed.2021.708140] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
26 Gutiérrez-Bautista JF, Rodriguez-Nicolas A, Rosales-Castillo A, López-Ruz MÁ, Martín-Casares AM, Fernández-Rubiales A, Anderson P, Garrido F, Ruiz-Cabello F, López-Nevot MÁ. Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients. J Microbiol Immunol Infect 2021:S1684-1182(21)00183-3. [PMID: 34475005 DOI: 10.1016/j.jmii.2021.08.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
27 San Segundo D, Arnáiz de Las Revillas F, Lamadrid-Perojo P, Comins-Boo A, González-Rico C, Alonso-Peña M, Irure-Ventura J, Olmos JM, Fariñas MC, López-Hoyos M. Innate and Adaptive Immune Assessment at Admission to Predict Clinical Outcome in COVID-19 Patients. Biomedicines 2021;9:917. [PMID: 34440121 DOI: 10.3390/biomedicines9080917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
28 Zhang S, Asquith B, Szydlo R, Tregoning JS, Pollock KM. Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact. Immunotherapy Advances 2021;1:ltab015. [DOI: 10.1093/immadv/ltab015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
29 Mahmoud Salehi Khesht A, Karpisheh V, Qubais Saeed B, Olegovna Zekiy A, Yapanto LM, Nabi Afjadi M, Aksoun M, Nasr Esfahani M, Aghakhani F, Movahed M, Joshi N, Abbaszadeh-Goudarzi K, Hallaj S, Ahmadi M, Dolati S, Mahmoodpoor A, Hashemi V, Jadidi-Niaragh F. Different T cell related immunological profiles in COVID-19 patients compared to healthy controls. Int Immunopharmacol 2021;97:107828. [PMID: 34091116 DOI: 10.1016/j.intimp.2021.107828] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
30 Gil-manso S, Blanco IM, Motyka B, Halpin A, Lopez-esteban R, Perez-fernandez VA, Carbonell D, López-fernández LA, West L, Correa-rocha R, Pion M. ABO blood group is involved in the quality of the specific immune response.. [DOI: 10.1101/2021.05.23.445114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Wang W, Thomas R, Oh J, Su DM. Thymic Aging May Be Associated with COVID-19 Pathophysiology in the Elderly. Cells 2021;10:628. [PMID: 33808998 DOI: 10.3390/cells10030628] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 16.0] [Reference Citation Analysis]